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The average time to reach half-maximal plasma concentration of prednisolone and the average 
plasma concentrations of prednisolone at 0.5 and 1 hr obtained from three crossover bioavailability 
studies, involving testing of commercially available 5-rag prednisone tablets, were highly correlated 
(r "~ 0.88) with parameters derived from in vitro tablet dissolution rates performed in the spin 
filter apparatus of Shah. The in vitro parameters were the times to dissolve 16%o or 50% of the 
labeled amount of prednisone or the percent of the labeled amount of prednisone dissolved in 20 rain 
in water at 37~ Such correlations may be useful in the setting of in vitro dissolution rate specifica- 
tions for commerical prednisone tablets. 
KEY WORDS: in vitro-in vivo correlations; predisone tablets; dissolution rates; spin filter 
apparatus; new in vivo parameter. 
INTRODUCTION 
The desirability of good correlations of variables derived from in vitro 
dissolution rates with variables derived from in vivo testing in human volun- 
teers is well established in biopharmaceutics. Some good quantitative 
correlations have been reviewed (1). 
This article presents a new type of in vitro-in vivo correlation based on 
parameters which are estimated by the logarithmic probability method of 
Wagner (2). 
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EXPERIMENTAL 
In Vitro Studies 
In vitro dissolution tests were performed on ten commercial 5-mg 
prednisone tablets made by different manufacturers. The dissolution medium 
was deaerated water at 37~ and the spin filter apparatus of Shah et al. (3) 
was used. 
In Vivo Studies 
Three separate bioavailability studies were performed in healthy adult 
male volunteers. The first study was a nine-subject three-treatment cross- 
over, while the second and third studies were 12-subject four-treatment 
crossovers. A 5-mg prednisone tablet manufactured by the Schering Cor- 
poration was used as a treatment in both the first and third studies. Doses of 
10 mg of prednisone were administered orally and venous blood samples 
were collected. Plasma concentrations of prednisolone, the active metabolite 
of prednisone, were determined by a radioimmunoassay method. The details 
and results of these studies have been presented elsewhere (4,5); the manu- 
facturer and lot numbers of the prednisone tablets are given in those reports. 
Treatment of Data 
One in vivo parameter was the time to reach half-maximal plasma 
concentration of prednisolone. The in vitro parameters, correlated with this 
in vivo parameter, were the times to dissolve 16% or 50% of the labeled 
amount of prednisone in water at 37~ using the spin filter apparatus. Both 
parameters were estimated by the logarithmic-probability method of 
Wagner (2). 
The logarithmic-probability method consists of plotting percent of 
label dissolved, or percent of peak plasma concentration, on the probability 
axis of logarithmic-probability graph paper and time on the logarithmic 
axis. The values of the parameters can then be estimated from the equations 
shown below. 
This procedure has been simplified by employing an electronic calcu- 
lator with a program which calculates the area under the standard (normal) 
probability distribution function (Z) and with a second program which 
calculates the parameters of a linear least-square line. The percentages of 
label dissolved, or percentages of peak plasma concentration values, are 
converted to Z values, then the least-squares Z vs. log t line is calculated, 
where t equals time. This line has an equation of the form 
Z = I + slog t (1) 
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w h e r e  I is the  i n t e r c e p t  a n d  s is the  s lope.  T h e  m e d i a n  (50 %) p o i n t  is t h e n  
ca l cu l a t ed  by m e a n s  o f  
tso ~ = a n t i l o g  ( -  1/s) (2) 
s ince Z = 0 for  the  m e d i a n .  T h e  e s t i m a t e d  t i m e  to  d i s so lve  16 % of  labe l  is 
c a l cu l a t ed  f r o m  
t 1 6 ~ * = a n t i l ~  - I - s  1 }  (3) 
C o r r e l a t i o n  coef f ic ien ts  were  c a l c u l a t e d  for t he  a v e r a g e  p l a s m a  p rec tn i so lone  
c o n c e n t r a t i o n  at  b o t h  0.5 a n d  1 h r  a n d  the  p e r c e n t  o f  t h e  l abe l ed  a m o u n t  o f  
p r e d n i s o l o n e  d i s so lved  in w a t e r  at  37~  in 20 ra in  in the  spin  f i l ter  a p p a r a t u s .  
R E S U L T S  A N D  D I S C U S S I O N  
In Vitro S t u d i e s  
T a b l e  I p r e sen t s  t he  m e a n  va lues  o f  six t ab le t s  o f  e a c h  lo t  for  p e r c e n t  o f  
l abe led  a m o u n t  o f  p r e d n i s o n e  d i s so lved  in the  spin  f i l ter  a p p a r a t u s  o f  Shah .  
M e a s u r e m e n t s  were  m a d e  at  400 r p m  for  60 min ,  t h e n  the  s t i r re r  speed  was  
i n c r e a s e d  to  800 r p m  a n d  a b s o r b a n c e  r e a d i n g s  were  t a k e n  unt i l  a c o n s t a n t  
a b s o r b a n c e  o r  " i n f i n i t y "  v a l u e  was  o b t a i n e d .  All  o f  the  t ab le t s  t e s ted  r e l eased  
Table I. Mean Values of Percent of Labeled Amount of Prednisone Dissolved from 5-rag 
Prednisone Tablets in Spin Filter Apparatus Using Deaerated Water at 37~ 
Mean percent dissolved from tablet 
Time 
(min) S U B N R L Mc M H D 
1 - -  19.1 . . . . . . . .  
2 68.8 55.8 . . . . . . . .  
3 89.3 79.6 . . . . . . . .  
4 95.3 90.6 . . . . . . . .  
5 96.1 95.3 19.4 14.3 7.1 22.6 16.8 2.4 2.5 1.8 
6 . . . . . . . . . .  
7 . . . . . . . . . .  
10 96.5 104 44.6 33.9 13.7 30.6 30.7 5.2 5.4 3.1 
15 - -  106 61.8 50.7 19.7 35.3 39.7 7.8 9.0 4.2 
20 96.8 107 70.5 66.2 24.9 39.7 45.5 10.4 13.1 5.3 
25 - -  - -  77.0 78.0 28.2 43.1 50.9 12.8 17.2 6.0 
30 - -  - -  80.4 86.6 30.4 45.3 54.5 15.0 20.6 7,2 
35 - -  - -  85.2 91.5 33.8 47.1 57.3 17.2 24.1 7.7 
40 - -  - -  86.5 94.4 36.4 48.9 61.7 19.4 27.4 8.4 
45 - -  - -  88.4 94.7 39.0 51.8 64.1 21.8 31.0 9.3 
50 - -  - -  91.0 95-4 41.5 53.3 65.9 24.3 33.8 9.7 
55 - -  - -  91.3 95.5 43.1 54.1 66.9 26.8 36.4 10.4 
60 - -  - -  92.2 95.7 43.7 56.1 69.6 29.1 38.9 10.4 
infinity 97.1 108 96.7 99.6 87.3 97.1 104 77.2 71.7 89.1 
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at least 70 ~ of the labeled amount of prednisone at the higher stirring speed, 
with most tablets yielding greater than 85 Yo of label dissolved. The dissolu- 
tion rates varied greatly among the tablets tested. Tablets S and U 4 released 
greater than 95 ~ of label in 5 min, while tablet D yielded only 10.4~ of 
labeled prednisone in 1 hr. The remaining tablets had intermediate rates of 
dissolution. 
In Vit,o Studies 
The results of the three bioavailability studies which were performed 
have been reported previously (4,5). 
Correlations 
An example of the logarithmic-probability graphs for the calculation 
of time to reach half-maximal plasma concentration is shown in Fig. 1. 
4To our knowledge, there are four 5-rag prednisone tablets which have effective NDAs, namely 
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Fig. 1. Sample logarithmic-probability plot for in vivo 
absorption data. 
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This figure illustrates the technique with the average plasma prednisone 
concentrations following oral administration of four of the tablets. In the 
actual application of the method, the individual subject or tablet data were 
averaged and prednisolone, not prednisone, plasma concentrations were 
employed. 
Table II lists the average in vitro and in vivo parameters and their 95 
confidence intervals for the ten commercial 5-rag prednisone tablets tested. 
The in vitro-in vivo correlation based on the time to reach half-maximal 
plasma concentrations and the time to dissolve 16~o of the labeled amount 
of prednisone in the spin filter apparatus is shown in Fig. 2. Tablets S, U, L, 
B, Mc, and N gave the same in vivo parameter within error (i.e., the averages 
did not differ significantly). The average in vivo parameter for these six 
tablets is shown as the dotted line drawn through these values. This agrees 
with theory in that there will be some range of in vitro rates of dissolution 
Table II. In Vitro-In Vivo Correlation Data for Prednisone Tablets 
In vitro: spin filter (water at 37~ time (rain) 
to dissolve indicated % of label 
Treatment 
Study in study 16~ 50~o 
In vivo : average time 
(rain) to reach half- 
maximal plasma 
concentration 
1 $1 0.916 a 1.53 29.8" 
(0.646-1.18) b (1.29-1.77) (12.6-47.0) 
3 Sa same same 24.14 
(11.6-31.5) 
2 U 0.925 1.78 24.2 d 
(0.859--0.991) (1.60-1.95) (8.0-30.4) 
3 B 4.13 11.7 31.4 d 
(3.74-4.52) (8.97-14.4) (15.2-47.7) 
2 N 5.83 14.5 23.8 d 
(4.76-6.90) ( ! 3.6-15.4) (19.8-27.8) 
2 R 12.0 80.0 39.64 
(9.69-14.3) (59.0-101) (25.2-54.0) 
3 L 2.60 42.6 26.74 
(2.16-3.04) (29.1-56.1) (13.1-41.5) 
3 Mc 5.14 29.7 34.1 a 
(3.09-7.19) (13.4--46.0) (16.4-51.7) 
1 M 37.8 94.0 61.5 c 
(29.1-46.5) (67.5-120) (47.6-75.4) 
1 H 25.7 79.9 47.2 c 
(21.5-29.9) (58.4-101) (34.3-55.1) 
2 D 116 1918 76.8 a 
(106-126) (1758-2078) (54.2-99.4) 
aAverage, based on six tablets. 
b95 ~ confidence limit of the average. 
CBased on nine subjects. 
~Based on 12 subjects. 
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Fig. 2. Correlation of average time to reach half-maximal plasma 
concentration of prednisolone with average time to dissolve 16~ of 
labeled amount prednisone in spin filter apparatus. 
where the in vivo measurement will not differ significantly, there will be some 
critical value of the in vitro parameter, and then further decrease in rate of 
dissolution will cause a progressive change in the in vivo parameter. In this 
case, the critical in vitro rate of dissolution appears to be near that of tablet 
N. Further increase in the in vitro parameter appeared to give a linear 
relationship between time to reach half-maximal plasma concentration and 
the logarithm of the time to dissolve 16 ~ of labeled amount of prednisone 
in deaerated water at 37~ in the spin filter apparatus. 
The least-squares line through these points has the equation 
~ =  8.84 + 31.31og t16 ~ (r = 0.959, p < 0.001) (4) 
where ~ is the estimated average time to reach half-maximal plasma predni- 
solone concentration. 
The correlation of the same in vivo parameter with the time to dissolve 
50~ of the labeled amount of prednisone is shown in Fig. 3. The same 
phenomenon of a critical value of the in vitro parameter is seen, but the 
correlation is not as good (lower r value) as the previous one. The equation 
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Fig. 3. Correlation of average time to reach half-maximal plasma concentration of 
prednisolone with average time to dissolve 50 ~o of labeled amount of prednisone in spin 
filter apparatus. 
(solid line) is 
-- 1.18 + 22.9 log t5070 (r = 0.890, 0.001 < p < 0.01) (5) 
Figures 4 and 5 illustrate two different types of regressions. Figure 4 is 
a plot of the average prednisolone plasma concentration at 0.5 hr after oral 
administration (Yo.5) vs. the logarithm of the average percent of labeled 
amount of prednisone dissolved in 20 min (~oD) in deaerated water at 37~ 
in the spin filter apparatus. Figure 5 is a plot of the average prednisolone 
plasma concentration at i hr after oral administration (Y1) vs. the same in 
vitro parameter as in Fig. 4. The least-squares lines drawn through the points 
in these two figures have the equations 
Yo.5 = 130 log %D - 77.5 (r = 0.915, p < 0.001) (6) 
Y1 = l131og ~oD + 18.9 (r = 0.879, p < 0.001) (7) 
It is interesting that the data in Figs. 4 and 5 do not show the same criticality 
of the in vitro parameter as Figs. 2 and 3. 
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Fig. 4. Correlation of average plasma prednisolone concentration in normal man 
at 0.5 hr with percent of labeled amount of predinisone dissolved in 20 min in 
spin filter apparatus (on log scale). Bars mark off 95~o confidence intervals 
of average. 
In interpreting Figs. 1-5 it should be noted that one of tablet H or M 
was previously reported (4) to have failed in clinical use. Hence it would 
appear reasonable to us to set dissolution rate specifications for prednisone 
tablets using tablet N as a "cutoff" point. The upper levels of the 95 
confidence intervals of the averages for these tablets are 16 ~o dissolved in 
6.9 min and 50~o dissolved in 15.4 min (Table II); in 15 min the mean per- 
cent dissolved for this tablet was 50.7 ~ and in 20 min the mean percent 
dissolved was 66.2 ~o (Table I). 
The National Center for Drug Analysis of the Food and Drug Ad- 
ministration has also obtained in vitro rate of dissolution data on the same 
prednisone tablets as those discussed here using paddle stirrer and the USP 
methods. Those data will be the subject of a separate report. 
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Fig. 5. Correlation of average plasma prednisolone concentration in normal man 
at 1 hr with percent of labeled amount of prednisolone dissolved in 20 min in 
spin filter apparatus (on log scale). Bars mark off 95% confidence intervals 
of averages. 
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